The Relation Between Swelling Properties and Enzymatic Degradation of Azo Polymers Designed for Colon-Specific Drug Delivery

[1]  J. Rokem,et al.  In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier , 1993, Pharmaceutical Research.

[2]  Jindřich Kopeček,et al.  Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo Degradation , 1992, Pharmaceutical Research.

[3]  V. Lee.  Oral Route of Peptide and Protein Drug Delivery , 1995 .

[4]  C. Samyn,et al.  Characterization of colon-specific azo polymers: A study of the swelling propertoes and the permeability of isolated polymer films , 1994 .

[5]  C. Samyn,et al.  Azo polymers for colon-specific drug delivery. II: Influence of the type of azo polymer on the degradation by intestinal microflora , 1993 .

[6]  E. Tomlinson,et al.  Colonic delivery of therapeutic peptides and proteins , 1993 .

[7]  C. Samyn,et al.  Azo polymers for colon-specific drug delivery , 1992 .

[8]  A. Sintov,et al.  Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery , 1992 .

[9]  H. Brøndsted,et al.  Hydrogels for site-specific oral drug delivery: synthesis and characterization. , 1991, Biomaterials.

[10]  J. Kopeček,et al.  Release of 5‐aminosalicylic acid from bioadhesive N‐(2‐hydroxypropyl)methacrylamide copolymers by azoreductases in vitro , 1990 .

[11]  G. Geisslinger,et al.  High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. , 1989, Journal of chromatography.

[12]  D. Neckers,et al.  A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.

[13]  D. Friend,et al.  Drug glycosides: potential prodrugs for colon-specific drug delivery. , 1985, Journal of medicinal chemistry.

[14]  D. Friend,et al.  A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. , 1984, Journal of medicinal chemistry.

[15]  A. Onderdonk,et al.  A polymeric drug for treatment of inflammatory bowel disease. , 1983, Journal of medicinal chemistry.

[16]  D. Williamson,et al.  Tissue and bacterial splitting of sulphasalazine. , 1983, Clinical science.

[17]  G. E. Fulk,et al.  Azo reduction of trypan blue to a known carcinogen by a cell-free extract of a human intestinal anaerobe. , 1978, Mutation research.

[18]  J. Larsen,et al.  Reduction of sulphonated water-soluble azo dyes by caecal microorganisms from the rat. , 2009, Acta pharmacologica et toxicologica.

[19]  P. Dubin,et al.  Reduction of azo food dyes in cultures of Proteus vulgaris. , 1975, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  R R Scheline,et al.  Metabolism of foreign compounds by gastrointestinal microorganisms. , 1973, Pharmacological reviews.

[21]  R. Walker,et al.  Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.